Enhanced immunogenicity of human papillomavirus 16 L1 genetic vaccines fused to an ER-targeting secretory signal peptide and RANTES
Open Access
- 14 July 2003
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 10 (15) , 1268-1273
- https://doi.org/10.1038/sj.gt.3301997
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Human secretory signal peptide description by hidden Markov model and generation of a strong artificial signal peptide for secreted protein expressionBiochemical and Biophysical Research Communications, 2002
- Genetic fusion of human insulin B‐chain to the B‐subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivoImmunology, 2002
- Pathways for internalization and recycling of the chemokine receptor CCR5Blood, 2002
- Parenteral and oral immunization with a plasmid DNA expressing the human papillomavirus 16‐L1 gene induces systemic and mucosal antibodies and cytotoxic T lymphocyte responsesJournal of Medical Virology, 2001
- RANTES-Induced Chemokine Cascade in Dendritic CellsThe Journal of Immunology, 2001
- A simple and efficient method for the monitoring of antigen-specific T cell responses using peptide pool arrays in a modified ELISpot assayJournal of Immunological Methods, 2001
- Epidemiologic and mucosal immunologic aspects of HPV infection and HPV-related cervical neoplasia in the lower female genital tract: A reviewInternational Journal of Gynecologic Cancer, 2001
- Nucleic Acid Vaccines Tasks and TacticsImmunologic Research, 2001
- Different fates of phagocytosed particles after delivery into macrophage lysosomes.The Journal of cell biology, 1996
- Synthesis and assembly of virus-like particles of human papillomaviruses type 6and Type 16 in fission yeast Schizosaccharomyces pombeVirology, 1995